Skip to content
News

Research shows overdoses cause irreversible brain injury

Urgent appeal for changes to addiction treatment FOR IMMEDIATE RELEASE August 25, 2026 Calgary, Alberta— Reversing an opioid overdose with naloxone is lifesaving, but it does not prevent some life-changing consequences, such as irreversible brain damage. A Letter to the Editor published in the globally renown journal Addiction is calling for change in how clinicians … Continued

Read Article
News

Alberta’s Correctional Health Services has transformed access to opioid addiction treatment for people in provincial correctional facilities.

FOR IMMEDIATE RELEASE July 14, 2026 Calgary, Alberta— People entering Alberta’s provincial correctional centres can now access treatment for opioid use disorder (OUD) in less than one day thanks to an innovative partnership between Correctional Health Services (CHS) and the Virtual Opioid Dependency Program (VODP). A new peer reviewed article published in Healthcare Quarterly and … Continued

Read Article
News

Global experts convene to design evaluation of Alberta’s Compassionate Intervention program

FOR IMMEDIATE RELEASE June 23, 2026 Calgary, Alberta—The Canadian Centre for Recovery Excellence (CoRE) is taking the next step in moving Alberta’s Compassionate Intervention (CI) program forward through establishment of a Compassionate Intervention Expert Group (CIEG). Led by CoRE’s Chief Scientific Officer, Dr. Nathaniel Day, the CIEG met in person for the first time on … Continued

Read Article
News

New peer-reviewed article explores buprenorphine’s potential as a novel harm reduction approach

FOR IMMEDIATE RELEASE June 2, 2026 CALGARY — A new peer-reviewed article published in Pharmaceuticals and co-authored by CoRE’s Chief Scientific Officer, Dr. Nathaniel Day, suggests buprenorphine, a medication commonly used to treat opioid use disorder, may also reduce the risk of fentanyl-induced respiratory depression, the primary cause of fatal opioid overdoses. The paper examines … Continued

Read Article
News

Landmark evidence shows closing Alberta Overdose Prevention Site led to no increase in overdose deaths and an increase in life-saving treatment 

FOR IMMEDIATE RELEASEMarch 10, 2026 Calgary, Alberta—Today, Addiction, the globally leading scientific journal, published CORE’s landmark findings on how the closure of an Overdose Prevention Site in Red Deer, Alberta did not result in increased deaths, emergency department visits, or EMS (ambulance) calls for site users and after the site closed, more site users sought … Continued

Read Article
Blog

Dr. Day’s presentation to UN Commission on Narcotic Drugs

At the 68th Annual UN Commission on Narcotic Drugs, Dr. Nathaniel Day, CoRE’s Chief Scientific Officer, presented to attendees representing close to 100 nations. He shared major efforts made in Alberta to address the crises of addiction in Canada. Securing this thought leadership opportunity is just one of CoRE’s strategic achievements in its first year … Continued

Read Article
News

CoRE Releases Position Paper Offering Crucial Insights on Risk of Cannabis Impairment in High-Risk Jobs 

FOR IMMEDIATE RELEASEJune 4, 2025 Calgary, Alberta—The Canadian Centre of Recovery Excellence (CoRE), in collaboration with Dr. Charl Els, is pleased to announce the publication of a new position paper, Cannabis in Safety-Sensitive Industries.  Endorsed by the Occupational and Environmental Medical Association of Canada (OEMAC), this paper has been published for peer review in the … Continued

Read Article

Media Inquiries

Reach out for media inquiries or interviews. We welcome any interest in CoRE and look forward to connecting.